Introduction and utilization of high priced HCV medicines across Europe; implications for the future

Henrik Krarup, Poul Schlichting, Alex Lund Laursen, Peer Brehm Christensen, Nina Weis, Mette Rye Clausen, Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011. Danish Medical Journal. ,vol. 59, ,(2012)

Bilgehan Aygen, Orhan Yildiz, Sila Akhan, Mustafa Kemal Celen, Onur Ural, Suda Tekin Koruk, Sukran Kose, Fatime Korkmaz, Ziya Kuruuzum, Nazan Tuna, Serpil Taheri, Murat Sayan, Nazlim Aktug Demir, Sua Sumer, Elif Sargin Altinok, Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey Balkan Medical Journal. ,vol. 32, pp. 266- 272 ,(2015) , 10.5152/BALKANMEDJ.2015.15366

W Lipworth, I Kerridge, N Ghinea, If we don’t talk about value, cancer drugs will become terminal for health systems The Conversation. ,(2015)

Markus Cornberg, Homie A. Razavi, Alfredo Alberti, Enos Bernasconi, Maria Buti, Curtis Cooper, Olav Dalgard, John F. Dillion, Robert Flisiak, Xavier Forns, Sona Frankova, Adrian Goldis, Ioannis Goulis, Waldemar Halota, Bela Hunyady, Martin Lagging, Angela Largen, Michael Makara, Spilios Manolakopoulos, Patrick Marcellin, Rui T. Marinho, Stanislas Pol, Thierry Poynard, Massimo Puoti, Olga Sagalova, Scott Sibbel, Krzysztof Simon, Carolyn Wallace, Kendra Young, Cihan Yurdaydin, Eli Zuckerman, Francesco Negro, Stefan Zeuzem, A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International. ,vol. 31, pp. 30- 60 ,(2011) , 10.1111/J.1478-3231.2011.02539.X

William Sievert, Ibrahim Altraif, Homie A. Razavi, Ayman Abdo, Ezzat Ali Ahmed, Ahmed AlOmair, Deepak Amarapurkar, Chien-Hung Chen, Xiaoguang Dou, Hisham El Khayat, Mohamed elShazly, Gamal Esmat, Richard Guan, Kwang-Hyub Han, Kazuhiko Koike, Angela Largen, Geoff McCaughan, Sherif Mogawer, Ali Monis, Arif Nawaz, Teerha Piratvisuth, Faisal M. Sanai, Ala I. Sharara, Scott Sibbel, Ajit Sood, Dong Jin Suh, Carolyn Wallace, Kendra Young, Francesco Negro, A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt Liver International. ,vol. 31, pp. 61- 80 ,(2011) , 10.1111/J.1478-3231.2011.02540.X

Nikolien van de Ven, Joe Fortunak, Bryony Simmons, Nathan Ford, Graham S. Cooke, Saye Khoo, Andrew Hill, Minimum target prices for production of direct‐acting antivirals and associated diagnostics to combat hepatitis C virus Hepatology. ,vol. 61, pp. 1174- 1182 ,(2015) , 10.1002/HEP.27641

Stéphane de Maeght, Peter Starkel, Jean-Pierre Mulkay, Isabelle Colle, Jean Delwaide, Sven Francque, Wim Laleman, Christophe Moreno, Hendrik Reynaert, Pierre Deltenre, Hans Orlent, Stefan Bourgeois, Update of the Belgian Association for the Study of the Liver Guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors. Acta Gastro-enterologica Belgica. ,vol. 75, pp. 245- 259 ,(2012)

Isabelle Andrieux-Meyer, Jennifer Cohn, Evaldo S Affonso de Araújo, Saeed S Hamid, Disparity in market prices for hepatitis C virus direct-acting drugs The Lancet Global Health. ,vol. 3, ,(2015) , 10.1016/S2214-109X(15)00156-4

Steven Simoens, Eline Picavet, Marc Dooms, David Cassiman, Thomas Morel, Cost-effectiveness assessment of orphan drugs: a scientific and political conundrum. Applied Health Economics and Health Policy. ,vol. 11, pp. 1- 3 ,(2013) , 10.1007/S40258-012-0004-Y

A. Hatzakis, S. Wait, J. Bruix, M. Buti, M. Carballo, M. Cavaleri, M. Colombo, E. Delarocque-Astagneau, G. Dusheiko, G. Esmat, R. Esteban, D. Goldberg, C. Gore, A. S. F. Lok, M. Manns, P. Marcellin, G. Papatheodoridis, A. Peterle, D. Prati, N. Piorkowsky, M. Rizzetto, F. Roudot-Thoraval, V. Soriano, H. C. Thomas, M. Thursz, D. Valla, P. van Damme, I. K. Veldhuijzen, H. Wedemeyer, L. Wiessing, A. R. Zanetti, H. L. A. Janssen, The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference* Journal of Viral Hepatitis. ,vol. 18, pp. 1- 16 ,(2011) , 10.1111/J.1365-2893.2011.01499.X